期刊
NEUROLOGY
卷 76, 期 17, 页码 1508-1513出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e3182181090
关键词
-
资金
- American Tourette Syndrome Association
- University of Sydney
- Tourette Syndrome Association, USA
- Brain Foundation Australia
- Trish Multiple Sclerosis Foundation Australia
- Otsuka Pharmaceutical Co., Ltd.
- Endo Pharmaceuticals (Indevus)
- Forest Laboratories, Inc.
- Janssen
- Shire plc
- NIH
- CDC
- Tourette Syndrome Association
- National Alliance for Research on Schizophrenia and Affective Disorders
- Robidoux Foundation
Objective: To test the hypothesis that Sydenham chorea (SC) immunoglobulin G (IgG) autoantibodies bind to specific neuronal surface proteins, whereas IgG from patients with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) or Tourette syndrome (TS) do not bind to neuronal surface proteins. Methods: We used live differentiated SH-SY5Y cells, which have neuronal and dopaminergic characteristics. Using flow cytometry, we measured serum IgG cell surface binding in patients with SC (n = 11), PANDAS (n = 12), and TS (n = 11), and compared the findings to healthy controls (n = 11) and other neurologic controls (n = 11). In order to determine the specificity of binding to neuronal antigens, we also used a non-neuronal cell line, HEK 293. Results: The mean IgG cell surface binding was significantly higher in the SC group compared to all other groups (p < 0.001). By contrast, there was no difference between the PANDAS or TS groups and the controls. Using the non-neuronal HEK-293 cells, there was no significant difference in IgG cell surface binding between any groups. Conclusions: Serum autoantibodies that bind to neuronal cell surface antigens are present in SC, but not in PANDAS or TS. These findings strengthen the hypothesis thatSCis due to a pathogenic autoantibody, but weaken the autoantibody hypothesis inPANDASand TS. Neurology (R) 2011;76:1508-1513
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据